Old Web
English
Sign In
Acemap
>
authorDetail
>
Hartmut Döhner
Hartmut Döhner
University of Cologne
Minimal residual disease
Rituximab
Immunology
Medicine
Fludarabine
2
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Standardized MRD Flow and ASO IGH RQ-PCR for MRD Quantification in CLL Patients after Rituximab-Containing Immunochemotherapy – a Comparative Analysis in 574 Samples from the Randomized GCLLSG CLL8 Trial
2008
Blood
Sebastian Boettcher
Stephan Stilgenbauer
R Busch
Monika Brüggemann
Thorsten Raff
Kirsten Fischer
Günter Fingerle-Rowson
Anna Maria Fink
Christiane Pott
Hartmut Döhner
Michael Hallek
Michael Kneba
Matthias Ritgen
Show All
Source
Cite
Save
Citations (1)
Quantitative MRD Assessments Predict Progression Free Survival in CLL Patients Treated with Fludarabine and Cyclophosphamide with or without Rituximab – a Prospective Analysis in 471 Patients from the Randomized GCLLSG CLL8 Trial
2008
Blood
Sebastian Boettcher
Kirsten Fischer
Stephan Stilgenbauer
R Busch
Günter Fingerle-Rowson
Anna Maria Fink
Hartmut Döhner
Michael Hallek
Michael Kneba
Matthias Ritgen
Show All
Source
Cite
Save
Citations (30)
1